Abstract | BACKGROUND:
Infection with the newly discovered human metapneumovirus (hMPV) may lead to hospitalization of children with lower respiratory tract infection (LRTI), although the pathogenesis thereof remains to be elucidated. METHODS: This hypothesis-generating study involved a cohort of children randomized to receive 9-valent conjugate pneumococcal vaccine or placebo and who were tested for hMPV infection when hospitalized for LRTI. By use of a nested reverse-transcription polymerase chain reaction assay targeted at amplifying a fragment of the hMPV fusion (F) protein gene, 202 such infections were identified among 2715 episodes of LRTI in children. RESULTS: Among human immunodeficiency virus (HIV)-uninfected children who had received 3 doses of conjugate pneumococcal vaccine, the incidence of hMPV-associated LRTI was reduced by 45% (95% confidence interval [CI], 19%-62%; P = .002), and the incidence of clinical pneumonia was reduced by 55% (95% CI, 22%-74%; P = .003). Similarly, in fully vaccinated HIV-infected children, the incidence of hMPV-associated LRTI was reduced by 53% (95% CI, 3%-77%; P = .035), and that of clinical pneumonia was reduced by 65% (95% CI, 19%-85%; P = .020). CONCLUSIONS: The pathogenesis of hMPV-associated LRTI that results in hospitalization of both HIV-infected and -uninfected children involves bacterial coinfection with pneumococcus, and a significant proportion of these hospitalizations may be prevented by vaccination with pneumococcal conjugate vaccine.
|
Authors | Shabir A Madhi, Herbert Ludewick, Locadiah Kuwanda, Nadia van Niekerk, Clare Cutland, Tessa Little, Keith P Klugman |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 193
Issue 9
Pg. 1236-43
(May 01 2006)
ISSN: 0022-1899 [Print] United States |
PMID | 16586360
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Pneumococcal Vaccines
- Vaccines, Conjugate
|
Topics |
- Child
- Child, Preschool
- Female
- Humans
- Male
- Metapneumovirus
(isolation & purification)
- Paramyxoviridae Infections
(complications, diagnosis, epidemiology)
- Pneumococcal Infections
(complications, prevention & control)
- Pneumococcal Vaccines
(therapeutic use)
- Pneumonia, Viral
(complications, diagnosis, epidemiology)
- Streptococcus pneumoniae
- Vaccines, Conjugate
(therapeutic use)
|